Health
Results: 4141-4152 of 8221

Genethon and Hansa Biopharma announce initiation of a Phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome

Sirius Therapeutics to Present Data from Its Phase 1 Clinical Trial of Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders at the 66th ASH Annual Meeting and Exposition

ReCerf® Hip Resurfacing Arthroplasty, from MatOrtho® Becomes the World's First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority







